Navigation Links
Despite A Difficult Competitive Environment, Opportunities Can Still Be Found In The Growing US Trauma Fixation Device Market
Date:11/14/2013

TORONTO, Nov. 14, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US trauma fixation device market will show continued growth over the forecast period despite considerable pricing pressure. Favorable demographics, such as the aging population, a rising number of sports injuries and growing obesity rates will be primary factors supporting procedure volume growth.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

Nonetheless, increased bargaining from hospital group purchasing organizations as well as expected cuts in reimbursement will put considerable pressure on prices through 2022. Additionally, innovation may be hampered by proposed changes to the regulatory environment, which would require trauma fixation devices to go through the premarket approval process as opposed to the less rigorous 510(k) approval system. This will slow the release of premium-priced products and, as a result, prices will decline going forward.

Companies are responding to these market pressures by expanding their market presence or altering their sales tactics. For instance, in order to expand its presence in the trauma market, Johnson & Johnson acquired Synthes in 2012. The subsequent spin-off of the former's trauma division to Biomet increased Biomet's portfolio of trauma fixation products. Stryker is focusing on specific segments, leveraging its leading position in the intramedullary (IM) nail market through the provision of innovative devices and by leveraging established relationships with group purchasing organizations in order to bolster its share in the lucrative anatomic plate and screw market. To mitigate difficulties in its extremities division, which includes trauma fixation devices, Smith & Nephew has recently reshuffled its organization to offer bulk purchasing discounts on a more aggressive scale in the hopes of appealing to cost-conscious customers.  

"Despite significant challenges, competitors in the US trauma device market have adopted creative strategies to maintain their revenues," said MRG Analyst Giridhar Madhusudhan. "Outside of general portfolio expansions through M&A and changes to sales tactics, companies are also focusing on niche segments of the market, such as deformity corrections and minimally invasive technologies, in order to generate revenues."

Millennium Research Group's US Markets for Trauma Devices 2014 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for plates and screws, IM nails, cannulated screws, dynamic hip screws, ancillary trauma devices, external fixation devices and long-bone stimulation devices in the United States.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
2. Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
3. Opportunities Exist Despite Challenges in Chinas API Market
4. Global Spinal Nonfusion Market to Grow to $1 Billion by 2017, Despite Challenges
5. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
6. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
7. Despite the Numerous Agents in Development for the Treatment of Chronic HCV Infections, a Notable Share of Physicians in Europe Lack Awareness of the HCV Pipeline
8. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
9. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
10. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
11. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):